Surgery for intractable XXXX : experience of a single institution.

@entity1 @entity410 @entity2026 @entity1315 @entity302
BACKGROUND/AIM: In the treatment of @entity302 , encouraging results have been achieved with surgical treatment, especially for @entity1315 ( @entity1315 ). Drug resistance must be diagnosed as early as possible, because the ensuing @entity410 can be eliminated surgically via temporal lobe surgery in a high percentage (70%-90%) of @entity1 . In this study we share our experience, in a single institution, of surgical treatment of intractable @entity1315 . MATERIALS AND METHODS: Between March 2006 and November 2010 we performed 127 corticoamygdalohippocampectomy (CAH) procedures. All CAH surgical procedures were done as described by Niemeyer's technique. Resection lengths were 4-4.5 cm from the temporal pole. RESULTS: At the end of 24 months, 79.7% (n = 94) @entity1 were still on antiepileptic medications, with 55 of them on a decreased number or dose of drugs, and 20.3 (n = 24) patients were antiepileptic drug-free. Postoperative Engel's classes were 1, 2, and 3 in 87.2%, 5.08%, and 7.6%, respectively. There was no mortality in follow-up, and @entity2026 in 1 @entity1 (0.84%) was the only morbidity. CONCLUSION: In our series we found that the outcome of surgery is associated with careful @entity1 selection, which requires a detailed investigation of the @entity1 . Our final conclusion is that outcome scores are independent of age, pathology, or sex but are dependent on correct @entity1 selection.
